Parties, docket activity and news coverage of federal case Mead v. Janssen Research & Development LLC et al, case number 2:19-cv-00106, from Louisiana ...
January 17, 2019 | Louisiana Eastern Walker v. Janssen Research & Development LLC et al. 367(Personal Injury: Health Care/Pharmaceutical Personal Injury ...
JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN ... JANSSEN RESEARCH AND DEVELOPMENT, LLC NICHOLAS MURRAY, Appellant v. ... All of the cases in this mass tort action consist of male plaintiffs who allege they ...... 682, 42 U.S.C. § 201 et seq. and was approved or licensed; or is generally ...
Mar 30, 2017 ... CRAIG, ET AL. v. JANSSEN RESEARCH AND DEVELOPMENT, LLC, ET AL.,. C.A. No. 5:17!00022. Eastern District of California. BREAUD v.
Oct 12, 2016 ... ... (S.D. Ill.), Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15 ... id. at * 8–*11. In Brazil v. Janssen Research & Development LLC, No.
Case Caption: HARTMAN ETAL VS JANSSEN PHARMACEUTICALS, INC. ETAL ... 6, 17, DEFENDANT, @9024730, JANSSEN PHARMACEUTICALS, INC. ..... JOHNSON, JANSSEN RESEARCH & DEVELOPMENT LLC AND JANSSEN ...
Robin L Thurmond of Janssen Research & Development, LLC, Raritan ( JANSSEN) ... with JNJ‐39758979 versus placebo at week 12 in pre‐specified subgroups with ..... This was hinted at by early work (Barger and Dale 1911; Abel and Kubota 1919) but was not shown conclusively until 1927 (Best et al. ...... Friedhelm Diel.
VR-CAP did not improve efficacy vs R-CHOP in non-GCB DLBCL. ..... For example, Gutiérrez-García et al demonstrated a correlation between the Hans and .... This work was supported by Janssen Research & Development, LLC. ...... Connors JM, Federico M, Diehl V, International Harmonization Project on Lymphoma.
Peter Hillmen,1 Joris Diels,2 Nollaig Healy,3 Wafae Iraqi,4 Johan Aschan,5 and Mark Wildgust6 .... Time on treatment for the international CLL NPP population versus the RESONATE™ .... and Jennifer Fuchs of PAREXEL, funded by Janssen Research & Development, LLC. ... Chanan-Khan A, Cramer P, Demirkan F, et al.